FDA Approves First In Class Targeted Therapy For Metastatic Pancreatic Cancer
https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer
A company got government approval for a new medicine that treats a serious type of cancer in a way nobody else has done before. This shows the company's research works, which is a big step—but we can't know yet if patients will use it or if the company will make money from it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.